News Opinion Editor's Corner AHA 2025 What’s Going to Be Hot at AHA 2025? Michael O'Riordan November 05, 2025
News Daily News PREVENT-TAHA8: Post-MI Intracoronary Stem Cells May Lower HF Risk After STEMI L.A. McKeown November 04, 2025
News Conference News TCT 2025 What Makes MedTech Great—or Not—and Envisioning Its Future Caitlin E. Cox November 04, 2025
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2025 Caitlin E. Cox November 03, 2025
News Conference News TCT 2025 AI-ECG Finds STEMI Faster, Cuts False-Positive Cath Lab Activations Todd Neale October 31, 2025
News Conference News TCT 2025 iFR-Guided Immediate PCI Not Superior to Deferred CMR-Guided Strategy in STEMI Yael L. Maxwell October 28, 2025
News Conference News TCT 2025 PROCTOR: PCI of Failed Bypass Grafts Tops Native-Vessel PCI, With Caveats Todd Neale October 28, 2025
News Conference News TCT 2025 STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus Michael O'Riordan October 28, 2025
Presentation TCT 2025 TCT 498: Comparative Effectiveness of GLP-1 Receptor Agonists vs. SGLT2 Inhibitors on Cardiovascular Outcomes in Patients with Diabetes Undergoing Percutaneous Coronary Intervention Presenter: Ahmed A. Mahmoud October 28, 2025
Presentation TCT 2025 TCT 494: Cost-Effectiveness of SGLT2 Inhibitors, Statins, and GLP-1 Receptor Agonists for Cardiovascular Secondary Prevention: A Comparative Analysis Presenter: Mehmet Cilingiroglu October 28, 2025
Presentation TCT 2025 TCT 499: Impact of GLP-1 Agonists on Cardiovascular Outcomes in Obese Adults with HFrEF receiving Guideline Directed Medical Therapy: A Propensity Score Matched Analysis Presenter: Dawood Shehzad October 28, 2025
Presentation TCT 2025 TCT 491: Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition on Platelet Reactivity in Patients with Atherosclerotic Cardiovascular Disease: A Pooled Analysis of Two Randomized Double-blind Placebo-controlled studies Presenter: Claudio Laudani October 28, 2025
Presentation TCT 2025 TCT 492: Sodium-Glucose Co-Transporter 2 Inhibitors on Cardiovascular Outcomes Post-PCI in Patients with Diabetes: Findings from the TriNetX Database Presenter: Aymen Ahmed October 28, 2025
Presentation TCT 2025 TCT 488: Sex-Based Differences in Cardiovascular Outcomes With Achieved LDL-C <55 mg/dL: A Comparative Cohort Analysis Presenter: Mehmet Cilingiroglu October 28, 2025
News Conference News TCT 2025 PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI Michael O'Riordan October 27, 2025
Presentation TCT 2025 TCT 964: Invisible Enemies of the Heart: An Umbrella Review of PM2.5 Exposure and Cardiovascular Risk Across Global Populations Presenter: Yashendra Sethi October 27, 2025
Presentation TCT 2025 TCT 1206: Clinical Presentation and Long-Term Outcomes of Patients Without Standard Modifiable Cardiovascular Risk Factors: Insight from the DECADE Cooperation Presenter: Claudio Laudani October 27, 2025
Presentation TCT 2025 First Report of the SPYRAL AFFIRM Study: Reduced Home and Office Blood Pressure Following Radiofrequency Renal Denervation in a Large US Cohort of High Cardiovascular Risk Patients. Presenter: Felix Mahfoud October 27, 2025
Presentation TCT 2025 TCT 1283: Clinical Presentation and Long-Term Outcomes of Patients Without Standard Modifiable Cardiovascular Risk Ffactors: Insight from the DECADE Cooperation Presenter: Claudio Laudani October 27, 2025
Presentation TCT 2025 TCT 485: Lipoprotein(a) and Long-Term Cardiovascular Events in Patients With Coronary Vasospasm Presenter: Melly Susanti October 27, 2025